Fundz

Watching Mobia Medical, Inc.? See every signal: funding, hires, M&A, contracts, sentiment.

Book a demoChoose your plan
Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly. See plans and pricing.See plans →
Back to SEC Filings
Executive ChangeItem 5.02 · 8-KLOW RiskPositive

Mobia Medical, Inc.

Filed: Jul 14, 2026CIK: 0001489993
View on SEC.gov

AI Executive Summary

AI-powered analysis of 8-K filing content

Mobia Medical expanded its Board of Directors from six to seven members by appointing Dr. Reza Zadno as a Class III independent director effective July 14, 2026, signaling a strategic effort to strengthen governance and board expertise.

Key Takeaways

Board size increased from 6 to 7 members with the appointment of Dr. Reza Zadno as Class III director

Dr. Zadno qualifies as an independent director and will serve on the Compensation Committee

2 more takeaways

Filing Overview

Form Type8-K
Filing DateJul 14, 2026
Item5.02
CategoryExecutive Change
CIK0001489993
Accession #0001489993
Risk LevelLOW
SentimentPositive
Signalinformational
Topics
board change

What This Means

A senior executive (CEO, CFO, etc.) has joined, departed, or changed roles. Leadership changes can significantly impact strategy.
View Full Filing on SEC.govBrowse More Filings

Mobia Medical, Inc. filed with the SEC. Fundz turns 8-K material events into an alert with the right executive attached.

145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.